Verona Pharma PLC (VRNA)
42.06
+0.84
(+2.04%)
USD |
NASDAQ |
Dec 20, 16:00
42.08
+0.02
(+0.05%)
After-Hours: 20:00
Verona Pharma Total Liabilities (Quarterly): 251.33M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| TC BioPharm (Holdings) PLC | 6.156M |
| Adaptimmune Therapeutics PLC | 237.45M |
| Biodexa Pharmaceuticals PLC | 6.628M |
| DBV Technologies SA | 39.02M |
| Autolus Therapeutics PLC | 350.52M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 381.82M |
| Shareholders Equity (Quarterly) | 130.49M |
| Debt to Equity Ratio | 0.9197 |
| Current Ratio | 13.03 |
| Net Debt Paydown Yield | -0.85% |